{
    "organizations": [],
    "uuid": "0c899c047f076d613c6be8c576215fbab029a398",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-jilin-province-huinan-changlong-bi/brief-jilin-province-huinan-changlong-bio-pharmacy-posts-qtrly-profit-attributable-rmb18-9-million-idUSFWN1S1110",
    "ord_in_thread": 0,
    "title": "BRIEF-Jilin Province Huinan Changlong Bio-Pharmacy Posts Qtrly Profit Attributable RMB18.9 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Jilin Province Huinan Changlong Bio-pharmacy Co Ltd:\n* QTRLY TURNOVER RMB160.5 MILLION VERSUS RMB153.1 MILLION * QTRLY PROFIT ATTRIBUTABLE TO EQUITY HOLDERS RMB18.9 MILLION VERSUS RMB17.9 MILLION\n* ON 24 APRIL 2018, A SPECIAL DIVIDEND OF RMB7 CENTS PER SHARE WAS PROPOSED Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-24T21:34:00.000+03:00",
    "crawled": "2018-04-25T14:14:36.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jilin",
        "province",
        "huinan",
        "changlong",
        "co",
        "ltd",
        "qtrly",
        "turnover",
        "million",
        "versus",
        "million",
        "qtrly",
        "profit",
        "attributable",
        "equity",
        "holder",
        "million",
        "versus",
        "million",
        "april",
        "special",
        "dividend",
        "rmb7",
        "cent",
        "per",
        "share",
        "proposed",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}